Number of the records: 1  

New 2,6,9-trisubstituted purine derivatives as Bcr-Abl and Btk inhibitors and as promising agents against leukemia

  1. 1.
    Bertrand, J., Dostálová, H., Kryštof, V., Jorda, R., Castro, A., Mella, J., Espinosa-Bustos, C., María Zarate, A., Salas, C. O. New 2,6,9-trisubstituted purine derivatives as Bcr-Abl and Btk inhibitors and as promising agents against leukemia. Bioorganic Chemistry. 2020, 94(JAN), 103361. ISSN 0045-2068. E-ISSN 1090-2120. Available: doi: 10.1016/j.bioorg.2019.103361.
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.